GlaxoSmithKline Plc EBITDA vs. Revenue
| GSKN Stock | MXN 739.40 0.57 0.08% |
For GlaxoSmithKline Plc profitability analysis, we use financial ratios and fundamental drivers that measure the ability of GlaxoSmithKline Plc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well GlaxoSmithKline plc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between GlaxoSmithKline Plc's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of GlaxoSmithKline plc over time as well as its relative position and ranking within its peers.
GlaxoSmithKline |
GlaxoSmithKline plc Revenue vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining GlaxoSmithKline Plc's current stock value. Our valuation model uses many indicators to compare GlaxoSmithKline Plc value to that of its competitors to determine the firm's financial worth. GlaxoSmithKline plc is one of the top stocks in ebitda category among its peers. It also is rated as one of the top companies in revenue category among its peers totaling about 3.33 of Revenue per EBITDA. Comparative valuation analysis is a catch-all model that can be used if you cannot value GlaxoSmithKline Plc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GlaxoSmithKline Plc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.GlaxoSmithKline Revenue vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
GlaxoSmithKline Plc |
| = | 8.8 B |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
GlaxoSmithKline Plc |
| = | 29.32 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
GlaxoSmithKline Revenue vs Competition
GlaxoSmithKline plc is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Drug Manufacturers—General industry is currently estimated at about 391.63 Billion. GlaxoSmithKline Plc holds roughly 29.32 Billion in revenue claiming about 7% of equities under Drug Manufacturers—General industry.
GlaxoSmithKline Plc Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in GlaxoSmithKline Plc, profitability is also one of the essential criteria for including it into their portfolios because, without profit, GlaxoSmithKline Plc will eventually generate negative long term returns. The profitability progress is the general direction of GlaxoSmithKline Plc's change in net profit over the period of time. It can combine multiple indicators of GlaxoSmithKline Plc, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GLAXOSMITHKLINE is traded on Mexico Stock Exchange in Mexico.
GlaxoSmithKline Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on GlaxoSmithKline Plc. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of GlaxoSmithKline Plc position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the GlaxoSmithKline Plc's important profitability drivers and their relationship over time.
Use GlaxoSmithKline Plc in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if GlaxoSmithKline Plc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlaxoSmithKline Plc will appreciate offsetting losses from the drop in the long position's value.GlaxoSmithKline Plc Pair Trading
GlaxoSmithKline plc Pair Trading Analysis
The ability to find closely correlated positions to GlaxoSmithKline Plc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GlaxoSmithKline Plc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GlaxoSmithKline Plc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GlaxoSmithKline plc to buy it.
The correlation of GlaxoSmithKline Plc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GlaxoSmithKline Plc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GlaxoSmithKline plc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GlaxoSmithKline Plc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your GlaxoSmithKline Plc position
In addition to having GlaxoSmithKline Plc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Manufacturing Thematic Idea Now
Manufacturing
Companies that provide goods across residential, commercial and industrial construction such as machinery, tools, or lumber production. The Manufacturing theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Manufacturing Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for GlaxoSmithKline Stock Analysis
When running GlaxoSmithKline Plc's price analysis, check to measure GlaxoSmithKline Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline Plc is operating at the current time. Most of GlaxoSmithKline Plc's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline Plc's price. Additionally, you may evaluate how the addition of GlaxoSmithKline Plc to your portfolios can decrease your overall portfolio volatility.